๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics and distribution of sulphadimidine in plasma, milk and uterine fluid of female buffaloes

โœ Scribed by M. K. Singh; C. Jayachandran; G. P. Roy; N. C. Banerjee


Book ID
104755562
Publisher
Springer Netherlands
Year
1988
Tongue
English
Weight
334 KB
Volume
12
Category
Article
ISSN
0165-7380

No coin nor oath required. For personal study only.

โœฆ Synopsis


Pharmacolcinetics and distribution of sulphadimidine in plasma, milk and uterine fluid of female buffaloes. Veterinary Research Communications, 12 (l), 41-46

The pharmacokinetics of sulphadimidine after a single dose (200 mg/kg i.v.) was studied in five healthy lactating buffaloes. The study revealed that the drug attained its peak concentration of 314.0+13.0, 242.4k3.0 and 100.2f2.5 pg/ml at 15 min, 30 min and 12 h in plasma, milk and uterine fluid, respectively. The pharmacokinetic parameters calculated by a 2-compartment open model gave values for ear, t& and vd,,, respectively. A high vd,, of 2.1OkO.36 h, 12.36kO.57 h and 1.23kO.07 UKg, as well as a value of 0.74f0.08 for K12:K21-fl (tissue = Plasma) indicates better penetration of the drug into the different body fluids and tissues, which is further supported by a high concentration obtained in milk and uterine fluid. The therapeutic concentration (350 @ml) was maintained for around 24 h in plasma and milk and 12 h in uterine fluid. The results suggest that, apart from its use in systemic infections, the drug can be effectively used by the iv. route in uterine and mammary gland infections. The dosages for maintaining concentration of 50 @ml, 100 &ml and 150 pg/ml at convenient dosage intervals of 12 and 24 h were also determined.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics and distribution of amp
โœ C. Jayachandran; M.K. Singh; N.C. Banerjee ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer Netherlands ๐ŸŒ English โš– 274 KB

A pharmacokinetic study of ampicillin (6 mg/kg intravenous) revealed that the peak concentrations of 17.81 +/- 1.25, 5.64 +/- 2.24 and 1.09 +/- 0.10 micrograms/ml of the drug were attained at 15 min, 30 min and 2 h in plasma, milk and uterine fluid respectively. A therapeutic concentration of greate